# DAPAGLIFLOZIN
> **ANDA216119** · Abbreviated New Drug Application (Generic) · Sponsor: JIANGSU HANSOH PHARM · Approved 2026-04-02
## Drug
- **FDA Application Number:** ANDA216119
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DAPAGLIFLOZIN
- **Generic name:** Dapagliflozin
- **Active ingredients:** DAPAGLIFLOZIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** JIANGSU HANSOH PHARM
- **First approval:** 2026-04-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216119)
---
*AI Analytics · CC0 1.0*